AFP is the most commonly used biomarker for the detection of HCC in clinical practice, but several studies have reported that in around 40% of HCC patients, the AFP expression level is normal, which indicates its low level of sensitivity [12,27]. Here, AFP is linked to hepatocellular carcinoma.